These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 30543848

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. LncRNA LINC00668 promotes cell proliferation, migration, invasion ability and EMT process in hepatocellular carcinoma by targeting miR-532-5p/YY1 axis.
    Xuan W, Zhou C, You G.
    Biosci Rep; 2020 May 29; 40(5):. PubMed ID: 32249890
    [Abstract] [Full Text] [Related]

  • 23. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, Tong X, Yang W, Xu Q, Huang D, Tu K.
    Mol Cancer; 2019 Feb 19; 18(1):28. PubMed ID: 30782188
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis.
    Liu Y, Geng X.
    Bioengineered; 2022 Feb 19; 13(2):3666-3679. PubMed ID: 35081873
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
    Wang YG, Wang T, Shi M, Zhai B.
    J Exp Clin Cancer Res; 2019 Apr 10; 38(1):153. PubMed ID: 30971290
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Long noncoding RNA PCAT-1 promotes invasion and metastasis via the miR-129-5p-HMGB1 signaling pathway in hepatocellular carcinoma.
    Zhang D, Cao J, Zhong Q, Zeng L, Cai C, Lei L, Zhang W, Liu F.
    Biomed Pharmacother; 2017 Nov 10; 95():1187-1193. PubMed ID: 28931210
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang C, Dou C, Xu M, Liu Q, Tu K.
    Mol Cancer; 2017 Jul 17; 16(1):123. PubMed ID: 28716020
    [Abstract] [Full Text] [Related]

  • 34. LncRNA SNHG1 promotes cell progression and metastasis via sponging miR-377-3p in hepatocellular carcinoma.
    Qu A, Yang Q.
    Neoplasma; 2020 May 17; 67(3):557-566. PubMed ID: 32122143
    [Abstract] [Full Text] [Related]

  • 35. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A.
    Yang Y, Hou N, Wang X, Wang L, Chang S, He K, Zhao Z, Zhao X, Song T, Huang C.
    Oncotarget; 2015 Jun 30; 6(18):16227-38. PubMed ID: 26023735
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
    Huang C, Li K, Huang R, Zhu J, Yang J.
    Life Sci; 2021 Feb 15; 267():118928. PubMed ID: 33358902
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.